Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study

MLA

Junyu Liang, et al. “Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study.” Frontiers in Medicine, vol. 8, Feb. 2021. EBSCOhost, https://doi.org/10.3389/fmed.2021.626953.

APA

Junyu Liang, Heng Cao, Yang Yang, Yini Ke, Ye Yu, Chuanyin Sun, Lihuan Yue, & Jin Lin. (2021). Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study. Frontiers in Medicine, 8. https://doi.org/10.3389/fmed.2021.626953

Chicago

Junyu Liang, Heng Cao, Yang Yang, Yini Ke, Ye Yu, Chuanyin Sun, Lihuan Yue, and Jin Lin. 2021. “Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study.” Frontiers in Medicine 8 (February). doi:10.3389/fmed.2021.626953.